Moneycontrol PRO

business

2013 in review: Pharma's year of quality woes

But the issues were not just restricted to compliance. As 2013 progressed, it unraveled a lot more dirt on corporate governance and oversight and forced the industry to do some serious soul searching.

first published: Dec 27, 2013 10:25 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347